Components of the pill reduce the rate of hospitalization and mortality from the disease by up to 88%, according to the Mexican health regulator
The health regulator of Mexico informed this Friday, 14th, that it granted emergency authorization to the Pfizer to treat Covid-19. The Federal Commission for the Protection of Health Risks (Cofepris) has declared that the drug will be used for adult patients with Covid-19 mild, moderate or at risk of complications. According to the agency, the use of the pill requires a medical prescription “considering the use and risk factors detailed in the authorization to avoid the misuse of this medication, self-medication and/or its irregular sale”. Cofepris also stated that the pill’s components reduce the hospitalization and mortality rate by Covid-19 by up to 88%. Mexico, with 126 million inhabitants, is experiencing a strong increase in infections at the beginning of 2022. On Wednesday, the country broke a historic record of positive cases with 44,187 records in 24 hours.
*With information from AFP